Search page

Amlitelimab (an OX40 ligand antibody) significantly reduces serum IgE and LDH, and epidermal hyperplasia in adults with moderate-to-severe atopic dermatitis

Amlitelimab Reduces Th2-, Th1-, and Th17/22-Related Gene Expression and Protein Levels in Adults With Moderate-to-Severe Atopic Dermatitis: Results From an Exploratory Analysis of the Phase 2b STREAM-AD Study

Analysis of Micro- and Macronutrient Levels in Children with Atopic Dermatitis Following BLW Complementary Feeding

Analysis of Positive Patch Test Allergens in Allergic Contact Dermatitis Patients with Atopic Dermatitis

Application of low-level laser with 1064nm Q-switched Nd: YAG laser may ameliorate atopic dermatitis

Approaching atopic dermatitis from a One Health Perspective

Assessment of Transepidermal Water Loss in Children with Atopic Dermatitis and Healthy Controls Using a Novel Device

Association between sputum immunoglobulin E and eosinophilic inflammation regardless of atopic status in asthmatics

Association between telomere length and atopic dermatitis among school-age children

Association of Allergic Sensitization Patterns and COVID-19 Manifestations in Georgian Atopic Patients

Association of serum IgE levels and atopic status with cancer in the general population

Atopic Dermatitis and Allergic Contact Dermatitis: Investigating the Role of Patch Testing

Atopic Dermatitis in Children: Exploring the Link between Skin/Blood Markers and Pulmonary Function

Atopic Dermatitis in Early Childhood: Linking Disease Severity, Food Sensitization, Biomarkers, and Airway Dysfunction

Atopic Dermatitis in the Mirror: Seeing Beyond the Symptoms

Atopic chronic dermatophytosis syndrome : an observational study to highlight the emergence of an interesting phenomenon

Atopic comorbidities: implications for the therapeutic decision

Atopic dermatitis : To test or not to test

Atopic dermatitis and pets

Atopic dermatitis patients with IL-22 response by House dust mite-activated circulating CLA+ memory T cells display a distinct molecular signature in lesional skin

Atopic dermatitis; the other side of the mirror

Autoantigens in autoimmune and atopic skin diseases

BBT001: A Novel Tetravalent Bispecific Antibody Targeting IL4Ra and IL31 for Enhanced Atopic Dermatitis Therapy

Baseline IgE Levels Predict an Unstable Disease Course in Adults With Severe Atopic Dermatitis That is Stabilized by Dupilumab Therapy

Beyond the scope of the skin: comorbidities and complications are frequent in atopic dermatitis

Biologicals for Atopic Dermatitis: Current Efficacy and Future Directions

Biologicals in atopic dermatitis

Biomarkers for Atopic Dermatitis: Towards Personalized Treatment

Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Epicutaneous Allergen-Induced Atopic Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117

Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey

Cannabinoid WIN55,212-2: Unlocking New Therapeutic Potential for Atopic Dermatitis by Restoring Skin Homeostasis

Childhood atopic dermatitis and air pollution

Chronic inflammatory skin diseases and primary atopic disorders

Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study

Clinical case discussion in atopic dermatitis

Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study

Comorbidities including infections and atopic conditions in CSU patients compared to healthy controls: results from the first, large, multinational case control study -RIFA-CU

Comparison of the proteomic profile in tears between patients with severe atopic dermatitis and severe asthma treated with Dupilumab

Concomitant treatment-resistant atopic dermatitis and psoriasis managed with upadacitinib: A case report

Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Correlation between air pollutants P.M.10, NO₂ and allergies in a cohort of atopic patients: a prospective cohort study

Corticosteroids in Atopic Dermatitis – A Love Hate Relationship?

DEFA1 gene expression in children with atopic dermatitis associated with opportunistic bacteria skin colonization

Dermatological Dichotomy: A Case of Coexisting Atopic Dermatitis and Mycosis Fungoides

Development and Validation of a Clinical Risk Score to Predict Pediatric Atopic Dermatitis in Utero

Discovery of Monoclonal IgE Autoantibodies from Atopic Dermatitis Patients

Does detection of S.aureus and resistance to antistaphylococcal drugs in blood cultures of hospitalized patients for infected atopic dermatitis change the hospitalization profile?

Dose reduction of dupilumab at 24 months of treatment in patients with controlled atopic dermatitis

Dual biological therapy with dupilumab and ixekizumab in a patient with asthma, nasal polyposis, atopic dermatitis and psoriasis

Dupilumab Is Efficacious in Children Aged 1–11 Years Weighing ≥15 kg With Eosinophilic Esophagitis Irrespective of Individual Atopic Comorbidities: 16-Week Results From the Phase 3 EoE KIDS Study

Dupilumab Treatment Reduces IgE Levels in Patients Aged 2 to 17 Years With Atopic Dermatitis, Asthma, and Eosinophilic Esophagitis

Dupilumab and emerging scores in children with Atopic Dermatitis: A 52 weeks monocentric prospective observational study

Dupilumab dose reduction in controlled severe atopic dermatitis and predictive factors

Dupilumab in Atopic dermatitis like eczema in IEI.

Dupilumab in Pediatric Patients with Severe Atopic Dermatitis: A Pilot Study

Dupilumab in Pediatric patients with moderate-to-severe Atopic Dermatitis

Dupilumab: Real-Life Effectiveness, Safety, and Impact on Type 2 and Non-Type 2 Comorbidities in Atopic Dermatitis Across Paediatric, Adolescent, and Adult Patients in Argentina – A 5-Year Review

Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis

EAACI & AAAAI Joint Symposium – Atopic Dermatitis 2025: Novel Pathophysiology & Treatment Insights

Early predictors of childhood atopic dermatitis

Early prognosis of Atopic Dermatitis (<3 years) and effect of Food Allergy

Educational Needs of Parents of Children with Atopic Dermatitis

Effectiveness of Dupilumab in improving Quality of Life in patients with “steroid-resistant” asthma and severe atopic dermatitis

Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study

Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study

Efficacy and Safety of Dupilumab in Children Aged 6 Months to 5 Years With Atopic Dermatitis With and Without Type 2 Comorbidities

Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis

Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD)

Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps

Efficacy of dupilumab in atopic dermatitis with prurigo : a real-life study

Electrical impedance spectroscopy detects skin barrier dysfunction in childhood atopic dermatitis

Emulsion containing a new chitosan derivative versus petrolatum in children with mild atopic dermatitis: a randomised controlled trial

Evaluation of Ykl-40 And Periostin Levels According to the Phenotype of Patients with Atopic Dermatitis

Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years

Evaluation of sleep quality, social-emotional development and parental stress levels of children with atopic dermatitis

Exploring a beta-lactoglobulin-based food for specific medical purposes (FSMP) for dietary management of chronic inflammation in atopic dermatitis: insights from mouse studies

Features of chronic spontaneous urticaria in patients with atopic comorbidities: Results from CURE, the chronic urticaria registry

First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma

Food Allergy and Atopic Dermatitis: A Complex Bidirectional Relationship

From Itch to Emergency: Eczema Herpeticum Threat in Atopic Dermatitis Patients

Future Atopic Dermatitis Treatment: Beyond IL-13 and JAK Inhibitors

Genetic aspects among Brazilian patients with Atopic Dermatitis: are Filaggrin variants relevant in the pathogenesis of the disease?

HNP1 expression dynamics in pediatric atopic dermatitis

House dust mite and staphylococcal enterotoxin B trigger heterogeneous IL-9 production by circulating skin-tropic and non-tropic memory T cells in patients with atopic dermatitis

How Food Allergen Sensitization Influences Asthma in Children with Atopic Dermatitis

How to manage the Atopic Dermatitis?

Human Papilloma Virus Infection During Pregnancy and Offspring Atopic Dermatitis

Human and computational models of atopic dermatitis

IgE autoantibodies in atopic dermatitis

Immune pathways impairment in severe atopy: the lesson learned from primary atopic disorders

Immune regulation of a prebiotic (GOS/Inulin) supplementation during pregnancy to prevent atopic dermatitis in children

Immune shift toward the IL-17 pathway: A case of paradoxical psoriasis in a patient with severe atopic dermatitis induced by dupilumab

Immunological and molecular characterization of a cohort of patients with severe atopic dysregulation in suspected or diagnosed Inborn Errors of Immunity

Impact of Eczema in Early Infancy on the Prevalence of Atopic Dermatitis and Food Allergy at the Age of 7 years: Insights From Sagamihara Allergy Cohort studies with a 12-year interval

Impact of aero allergens and microbes on atopic dermatitis

Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis

Impact of sensitization to main allergen molecules during childhood on adult asthma, atopic dermatitis, rhinitis and food allergy in the BAMSE cohort

Impact on sexual health of clinical control in atopic dermatitis

Inborn errors of immunity presenting as atopic disorders

Inborn errors of immunity with atopic manifestations

Inborn errors of immunity with atopic phenotype

Inborn errors of immunity with atopic phenotypes

Individual management of atopic dermatitis according to phenotypes and co-morbidities

Infant atopic dermatitis and maternal anxiety and depression: a mixed methods case-control study

Insufficient use of emollients and moisturizers in children with atopic dermatitis

Integrated Safety Analysis of Abrocitinib in 3848 Patients With Moderate-To-Severe Atopic Dermatitis: Data From More Than 7000 Patient-Years With Up to 4.5 Years of Exposure

Inverse Association between Mitochondrial DNA Copy Number and Atopic Dermatitis in Schoolchildren

Investigation of cellular infiltrate in atopic dermatitis

Investigation of the inflammatory profile in tears of severe atopic dermatitis patients treated with dupilumab. A study of the BIOBADALER consortium

Involvement of periostin-dependent and -independent pathways in the formation of skin inflammation and itch in a mouse model of atopic dermatitis

JAK Inhibitors for Atopic Dermatitis: A New Frontier in Treatment

Long term impact of formula choice in children with cow milk protein allergy: 6-year follow-up of the Atopic March Cohort Study

Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study

Long-Term Efficacy and Safety of Stapokibart in Patients with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Pivotal Phase 3 Trial

Longitudinal Outcome of Dupilumab for Children and Adolescents with Atopic Dermatitis: An Asian Perspective

Low fecal butyrate levels at the age of one year is associated with an increased risk of atopic dermatitis in early childhood

MOLECULAR IgE SENSITIZATION PROFILE IN A PATIENT WITH ADULT ATOPIC DERMATITIS AND CHRONIC URTICARIA SYNDROME TO FOODS

MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Machine Learning Predictive Modeling of Pediatric Atopic Dermatitis Using Population-Based Electronic Health Records

Management of Atopic dermatitis patients under the scope of Treat to target (T2T)– Real world data of remission induction stage

Management of Chronic Spontaneous Urticaria and Atopic Dermatitis with Omalizumab: A Case Report Highlighting Efficacy and Emerging Challenges

Management of atopic dermatitis: What would you have done?

Measurement of Transepidermal Water Loss in children with atopic dermatitis and healthy controls using a new technology

Measurement of nocturnal scratch using a smart watch app in pediatric patients with atopic dermatitis

Mental health support for atopic dermatitis patients in the Republic of Kazakhstan

Metabolomic and proteomic characteristics of food allergy in pediatric patients with atopic dermatitis

Molecular techniques to assess for atopic sensitization in the era of climate change. What is new?

National trendNational trends and disparities in complementary food diversity for infants with atopic dermatitis: A 12-year cross-sectional cohort study of births

Nationwide Big Data Analysis of Atopic Dermatitis Treatments in Japan: Real-World Findings on the Impact of Dupilumab

New horizons in the management of severe atopic dermatitis

New insights in pathogenesis of atopic dermatitis

New treatment options in childhood atopic dermatitis

New trends in atopic dermatitis

Novel JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease

Objective and Subjective Sleep Assessments in Patients With Atopic Dermatitis Treated With Dupilumab: Results From DUPISTAD, a Phase 4 Randomized Placebo-Controlled Study

Oral Administration of Ginsenoside F1 Attenuates Allergic Atopic Dermatitis by Modulating T cell Activation

Oral allergy syndrome as a marker of food allergy in a monocentric cohort of atopic patients with eosinophilic esophagitis

Patch tests in atopic dermatitis

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Stapokibart in Healthy and Atopic Dermatitis Adult Subjects

Pink peppercorn: low cross-reactivity in a high-risk pistachio allergic patient with atopic dermatitis and indolent systemic mastocytosis

Postgraduate Course 1: Immunonutrition and atopic disorders

Prenatal maternal supplementation with prebiotics regulates microbiota colonization in high-risk children, but do not prevent atopic dermatitis at one year of age

Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab

Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases is Increasing in Korean Children and Adolescents

Prevalence of sensitization to aeroallergens among atopic children in Ukraine

Primary atopic disorders

Pustular psoriasis of von Zumbusch under the mask of atopic dermatitis in an infant

Questionnaire survey of new treatments for atopic dermatitis

ROAD Study: Long-term Efficacy and Safety of Topical Therapy in Pediatric Moderate to Severe Atopic Dermatitis

Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years

Real-world clinical experience with dupilumab use in 33 children with severe atopic dermatitis

Real-world use of topical treatments for children with atopic eczema: a systematic review

Reduced Natural Moisturizing Factors and Caspase-14 Impaired Skin Barrier Function for Pediatric Atopic Dermatitis in Japan

Relationship between the severity of atopic dermatitis and quality of life in children and adults attending an allergy clinic in Colombia between 2018-2020: A marginal mean weighting through stratification analysis (MMWS)

Respiratory Allergies and Sensitization Patterns to Pollen in European and Sub-Saharan African Patients with Atopic Dermatitis

Revealing Wheeze-like Bronchial Obstruction in Infants with Atopic Dermatitis Using Tidal Breathing Analysis

Risk factors determining the development of food allergy intolerance at the first age in infants with atopic dermatitis

Role of the single nucleotide variants of filaggrin, thymic stromal lymphopoietin and orsomucoid-1-like protein 3 in the development of atopic bronchial asthma phenotypes in children

Safety and compliance of sublingual immunotherapy with house dust mite extract in patients with atopic dermatitis for 1 year

Serum Lactate Dehydrogenase levels distinguish atopic dermatitis patients with a predominant production of IL-13, IL-5 and IL-9 in response to house dust mite allergen and increased prevalence of allergic comorbidities

Severe Atopic Dermatitis and HyperEosinophilic Syndrome in Children Undergoing Dupilumab Treatment: Report of two cases

Severe atopic dermatitis and upadacitinib: tertiary care outpatient experience

Severe atopic dermatitis poorly controlled, or something else?

Severe atopic dermatitis: a stand-alone disease or something more?

Should dupilumab be the standard first treatment choice for severe atopic dermatitis?

Skin microbiome composition in children with atopic dermatitis

Sleep Quality In Parents And Children With Atopic Dermatitis In Early Childhood (<3 years)

Study on the target level and influencing factors of dupilumab treatment in children with moderate to severe atopic dermatitis

Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective

Th2 Biologics in primary atopic disorders: the ATO-PID EAACI task force

The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis

The Fecal Microbiome: Geographical Location and Associated Dietary Habits Matter More Than Atopic Dermatitis

The Psychological Burden of Atopic Dermatitis:Assessing Anxiety and Depression Prevalence with the HADS Scale in Argentina

The Socio-Economic Impact of Atopic Dermatitis and Alopecia Areata

The effectiveness and safety of Abrocitinib treatment for severe atopic dermatitis in the real-world data in Turkey

The expanding field of Primary Atopic Disorders and their management

The growth dynamics of Staphylococcus species isolated from atopic dermatitis patients in Hong Kong and the United Kingdom

The impact of asthma and mental health condition multimorbidity in national samples of Canadian children

The impact of food allergens on atopic dermatitis

The influence of micronutrients in a child’s body on the manifestations of atopic dermatitis

The integral precision model for personalized genotype-associated predictive diagnostics of atopic dermatitis in children

The prevalence and management features of adolescents with atopic dermatitis under humanitarian crisis

The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis

The role of sirtuin 2 (SIRT2) in atopic dermatitis

The spectrum of sensitization in atopic dermatitis in patients living in the Far East of Russia

Therapeutic Potential of LCAA-PSF in Atopic Dermatitis: Insights from an MC903-Induced Mouse Model

Therapeutic effectiveness and safety of cannabinoids in the treatment of atopic dermatitis: a systematic review

Transepidermal Water Loss in Atopic Diseases

Transepidermal water loss in atopic conditions

Transepidermal water loss measurement on the second day after birth can predict the development of atopic dermatitis during the first three months of life

Treatment of atopic dermatitis patients with dupilumab restores functional responses of circulating skin-homing CD4+ T and B cells

Treatment of severe atopic dermatitis in pediatric patients with Dupilumab and effects of therapy on nasal and skin microbiota: preliminary experimental evidence

Untargeted proteomics identifies key inflammation and barrier dysfunction networks defining a unique signature for Asian Atopic Dermatitis (AAD)

Unveiling the Underlying Mechanism of Differentiation for STAR-0310, an Anti-OX40 Antibody for Atopic Dermatitis

Urinary Levels of Environmental Pollutants Are Associated with the Severity and Persistence of Atopic Dermatitis in Young Children

Vernal and Atopic Keratoconjunctivitis: disease spectrum or different entities?

Vitamin D Receptor Gene Single Nucleotide Polymorphism rs11168293 Association with Atopic Diseases

Evolution of atopic keratoconjunctivitis in patients with severe to moderate atopic dermatitis treated with oral Janus kinase inhibitors

Genome-wide association study identifies CACNA2D3 associated with asthma and atopic dermatitis multimorbidity in children

Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website